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Abstract A fibrosarcoma cell line transfected with the matrix
metalloproteinase MT1 MMP showed an enhanced ability to
degrade 14C-labelled collagen films. As previously shown for
proMMP 2 activation, TIMP 1 was an ineffective inhibitor of
the process of collagenolysis whereas TIMP 2 was efficient and
completely prevented collagen degradation. In the presence of the
calcium ionophore, ionomycin, proteolytic processing of MT1
MMP was restricted and collagenolysis did not occur indicating
that the 63 kDa form of the enzyme is not a functional
collagenase. The collagenolytic activity of MT1 MMP was
shown to be enhanced by the addition of proMMP 2, but TIMP 1
inhibition remained poor relative to that of TIMP 2. The study
demonstrated that synergy between two non-conventional
collagenases effectively degrades insoluble pericellular collagen.
Due to the membrane localisation of MT1 MMP, this could
potentially occur in a highly localised manner. ß 2001 Feder-
ation of European Biochemical Societies. Published by Elsevier
Science B.V. All rights reserved.
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1. Introduction
Membrane type matrix metalloproteinases (MT MMPs) are
a subset of the matrix metalloproteinase (MMP) family of
enzymes which together are capable of degrading the macro-
molecular components of the extracellular matrix (ECM).
MT1 MMP (MMP 14) is the ¢rst member of this subset which
are distinguished by the presence of a transmembrane domain
and a short cytoplasmic ‘tail’ [1]. In addition they have the
propeptide domain, zinc binding catalytic domain and hemo-
pexin-like C-terminal domain of the soluble MMPs. A further
characteristic of this membrane associated subset is the pres-
ence of a furin recognition site in the propeptide allowing
activation by the furin-like proprotein convertases. Many re-
ports to date have emphasised the ability to activate progela-
tinase A (MMP 2) as the major function of MT1 MMP in
vivo [2]. This is believed to involve the formation of a MT1
MMP-TIMP 2 ‘receptor’ on the surface of activated cells
which enables binding of proMMP 2 and initiates a two
step activation cascade by adjacent TIMP 2 free MT1 MMP
[3^6]. A parallel cell surface activation mechanism is proposed
for MMP 13 [7,8] which, unlike MMP 2, may also be acti-
vated, in common with other soluble MMPs, by activation
cascades involving plasmin.
Biochemical studies using recombinant soluble MT1 MMP
have shown that MT1 MMP has powerful proteolytic proper-
ties against a range of macromolecular substrates [9^11] in-
cluding ¢bronectin, tenascin, nidogen, aggrecan and perlecan.
It can also cleave ¢brillar collagens at a speci¢c locus resulting
in the 3/4, 1/4 fragments typically generated by the activity of
the neutral collagenases, MMP 1, MMP 8 and MMP 13. In
common with these MMPs the C-terminal hemopexin-like
domain of MT1 MMP is essential for this activity. These
data on the soluble proteinase suggest that cell associated
MT1 MMP may function as an e⁄cient collagenase in vivo
unless its membrane localisation precludes access to the sub-
strate. A recent report describes severe skeletal defects exhib-
ited by MT1 MMP de¢cient mice [12]. These include cranio-
facial dysmorphism, dwar¢sm, osteopenia, arthritis and
¢brosis of soft tissues. Preliminary studies also demonstrated
that skin ¢broblasts from new born MT1 MMP de¢cient mice
were unable to degrade reconstituted type 1 collagen ¢lms
when stimulated by IL1-L or TNF-K. It was concluded that
the phenotype was due to inadequate collagen turnover owing
to the failure of collagenolytic and gelatinolytic activity by
MT1 MMP. Additionally, Hotary et al. [13] demonstrated
that MDCK cells cultured on type 1 collagen matrices were
induced to invade and form tubular networks in response to
scatter factor/HGF. This behaviour was not modi¢ed by over-
expression of soluble MMPs, 1, 2, 3, 7, 9, 11 or 13 but was
accelerated by transfection of MDCK cells with MT1 MMP
and accompanied by complete degradation of the collagen in
the presence of HGF.
We have previously demonstrated the ability of cell associ-
ated MT1 MMP to degrade gelatin both directly and indi-
rectly by the activation of MMP 2 [14]. In this report we
have used an established human cell model to further examine
and quantify the speci¢c collagenolytic potential of MT1
MMP. Human ¢brosarcoma HT1080 cells which can be in-
duced to overexpress MT1 MMP were cultured on 14C-la-
belled type 1 collagen ¢lms in order to determine to what
extent the collagenolytic activity of these cells is MT1 MMP
dependent. Additionally we asked whether MT1 MMP and
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MMP 2, when presented together at the cell surface, are able
to cooperate in focussed degradation of the pericellular ECM,
and the extent to which TIMPs may regulate this process.
2. Materials and methods
2.1. Inducible expression of MT1 MMP using the Tet-o¡ system
A HT1080 human ¢brosarcoma cell line, HTC 75, into which the
pTet-o¡ control element had been stably transfected (kindly provided
by Dr B. van Steensel, Rockefeller University, New York, USA) was
further transfected with human MT1 MMP cDNA (generous gift
from Professor M. Seiki, University of Tokyo, Japan) using the
pTRE plasmid and pSV2neo (for selection) as described by Butler
et al. [15]. Highly expressing stable clones were selected by screening
for MT1 MMP using gelatin zymography (see below) to detect acti-
vation of endogenous MMP 2. Clone L163 #6 was chosen for these
studies in which gene transcription could be repressed in the presence
of 100 ng/ml doxycycline (Sigma, UK). Cells were maintained in
DMEM and 10% FCS containing 500 Wg/ml geneticin (Gibco Life
technologies) and 100 ng/ml doxycycline (Sigma) prior to use.
2.2. Immunolocalisation of MT1 MMP
HTC 75 cells were seeded at 104 cells/well in the presence or ab-
sence of 100 ng/ml of doxycycline in DMEM with 10% FCS (tet
approved for induced cells) in four-well chamber slides (Falcon).
Cells were incubated at 37‡C, 5% CO2 for 24 h and then washed,
¢xed and stained by indirect immuno£uorescence for MT1 MMP
expression using a polyclonal antibody raised in sheep against human
MT1 MMP as previously described [14].
2.3. Preparation of 14C-labelled type 1 collagen ¢lms
Radiolabelled collagen ¢lms were prepared in 24-well tissue culture
plates essentially as previously described [16], but with minor modi¢-
cations. Aliquots of 14C acetylated rat skin type 1 collagen (150 Wg
(10 000 dpm) in 300 Wl 10 mM sodium phosphate bu¡er pH 7.4 con-
taining 300 mM NaCl and 0.02% NaN3) were dispensed into culture
wells and incubated for 2 h at 37‡C. They were then left overnight in a
laminar £ow culture hood so that the collagen dried into ¢lms. The
¢lms were washed twice with sterile distilled water to remove salt
crystals and azide before equilibrating with two changes of DMEM
followed by plating the cells.
2.4. Culture of HTC 75 cells on 14C collagen ¢lms
The cells were seeded onto the ¢lms at 105 cells/well in DMEM and
10% FCS and 100 ng/ml doxycycline (for uninduced cells) or DMEM
and 10% tet approved FCS (Clontech). Cells were left to attach over-
night at 37‡C then the medium was removed, the cells washed free of
serum and replaced by 300 Wl/well DMEM and ITS (insulin, trans-
ferrin and selenium liquid supplements (Sigma)), with or without 100
ng/ml doxycycline. TIMP 1, TIMP 2 or ionomycin (Sigma) were in-
cluded in some experiments. In others exogenous proMMP 2 was also
included. The cells were incubated at 37‡C for 24 h and 48 h, harvest-
ing and replacing medium at each time point. At the end of the
experiments any remaining collagen was digested using 50 Wg/ml bac-
terial collagenase (Roche Diagnostics). 14C released into the super-
natants was counted (100 Wl sample) in a liquid scintillation counter.
The remaining supernatants were analysed for MMP 2 activation by
gelatin zymography. In some experiments cell lysates were prepared
for Western blotting to detect MT1 MMP or MMP 1.
2.5. Puri¢cation and preparation of TIMPs
Recombinant forms of TIMP 1 and TIMP 2 were expressed and
puri¢ed from transfected NSq mouse myeloma cells as previously
described [17,18], dialysed into phosphate bu¡ered saline and ¢lter
sterilised.
2.6. Gelatin zymography
Cell supernatants were analysed by gelatin zymography in order to
monitor MMP 2 processing/activation as an indication of the activity
of MT1 MMP by the induced cells. Samples of supernatants
were electrophoresed on 7% polyacrylamide SDS gels which had
0.5 mg/ml gelatin incorporated into them and stained with Coomassie
Brilliant Blue [19].
2.7. Western blotting
Cell lysates were prepared as described by Stanton et al. [20] and
protein content was determined using the BCA assay (Sigma, UK).
Aliquots containing equivalent amounts of protein were run on 10%
polyacrylamide SDS gels, transferred to nitrocellulose using a semi-
dry blotter and probed for MT1 MMP using a sheep polyclonal anti-
body to human MT1 MMP [14]. Blots were visualised using the ECL
detection system (Pierce Warriner, UK). Cell supernatants were con-
centrated 3^5-fold and blotted or analysed by ELISA for the detection
of MMP 1.
3. Results and discussion
3.1. Transfected HTC 75 cells express MT1 MMP at the cell
surface when repression of gene transcription is removed
HT1080 cells are known to express endogenous MT1 MMP
which, in unstimulated cells, is retained in an as yet unidenti-
¢ed intracellular compartment. Upon stimulation, for exam-
ple by phorbol esters or by culturing on ECM components
such as ¢bronectin or collagen, MT1 MMP is thought to be
recruited to the plasma membrane by tra⁄cking events which
Fig. 1. HTC 75 cells in the absence (a) or presence (b) of doxycycline were stained without permeabilisation for MT1 MMP expression as de-
scribed in the text. Cell surface staining can be seen in cells induced to express MT1 MMP by removal of doxycycline whereas none is apparent
in the uninduced cells. Bar = 50 Wm.
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remain to be elucidated. At the cell surface it participates in
proMMP 2 activation [3,20,21]. The inducible cell line which
we have established expressed high levels of MT1 MMP on
the cell surface as detected by indirect immuno£uorescence
when repression of gene transcription was removed by cultur-
ing the cells in the absence of doxycycline (Fig. 1). This in-
ducible expression allowed us to examine how cell surface
associated MT1 MMP contributes to the proteolysis of the
pericellular ECM in the form of a collagen ¢lm model.
3.2. MT1 MMP expressing cells show an enhanced ability to
degrade collagen
Cells over-expressing MT1 MMP degraded the collagen
¢lms up to four times more e⁄ciently than the non-expressing
cells after 24 h (Fig. 2a). Analysis of the culture supernatants
by gelatin zymography showed the presence of both MMP 9
and MMP 2. MMP 9 was detected only in the inactive pro-
form (92 kDa) in all the samples whether or not the cells were
induced. At 24 h, MMP 2 in supernatants from induced cells
was all in the fully active (59 kDa) form (Fig. 2b, lanes 3 and
4) compared to that detected in supernatants from repressed
cells where approximately 90% was in the proform (66 kDa)
(Fig. 2b, lanes 1 and 2). However by 48 h approximately 50%
of MMP 2 in the supernatants from non-induced cells could
be detected in the fully active form (Fig. 2c, lanes 1 and 2).
These results di¡er from experiments in which the inducible
cells are grown on tissue culture plastic. Gelatin zymography
of culture supernatants from these experiments demonstrated
that MMP 2 is not activated by the repressed cells even after
48 h incubation indicating that MMP 2 activation by these
cells cultured on plastic is MT1 MMP dependent (data not
shown). MMP 2 activation by the repressed cells cultured on
14C collagen con¢rms earlier reports of MMP 2 activation
induced by ECM components [21] and is likely to be due to
the endogenous levels of MT1 MMP present in these cells.
The levels are low however since only a limited increase in
14C collagen degradation was seen between 24 and 48 h and
the induced cells still showed enhanced collagenolysis com-
pared to the repressed cells.
3.3. Collagenolysis by MT1 MMP expressing cells is inhibited
by TIMP 2
The contribution of MT1 MMP to collagenolysis was fur-
ther con¢rmed by the di¡erent inhibition pro¢les seen with
TIMP 1 and TIMP 2 (Fig. 3a). MT1 MMP expressing cells
incubated in the presence of 1 WM TIMP 1 degraded the
collagen by 10% less than those incubated alone. At lower
concentrations there was less inhibition of collagenolysis and
indeed some apparent protection of the intact enzyme and
hence potentiation at 100 nM. TIMP 1 is known to be a
poor inhibitor of MT1 MMP [4,22] whereas it is an e⁄cient
inhibitor of MMP 2 in vitro. TIMP 2 inhibited collagenolysis
by MT1 MMP expressing cells in a dose dependent manner.
Only 10% inhibition was observed with a dose of 100 nM
TIMP 2 but at 500 nM, TIMP 2 completely inhibited degra-
Fig. 2. HTC 75 cells were cultured, as described in the text, on 14C
collagen ¢lms in the presence (light shading) or absence (dark shad-
ing) of 100 ng/ml doxycycline for 24 or 48 h. Radioactive counts re-
leased into the cell supernatants after each time point are shown as
a percentage of the total counts (a). Each bar represents the mean
of four replicate wells. Values from cell free control wells have been
subtracted (2^5%). Aliquots of supernatants from the same experi-
ment were analysed on gelatin zymograms as described. Lanes 1
and 2, supernatants from uninduced cells; lanes 3 and 4, superna-
tants from induced cells. 24 h (b), 48 h (c). Note that approximately
50% MMP 2 is in the active form in 48 h supernatants from unin-
duced cells as explained in Section 3.
Fig. 3. a: HTC 75 cells were cultured for 24 or 48 h on 14C-labelled
collagen ¢lms in the presence or absence of doxycycline and varying
amounts of TIMP 1 (8) or TIMP 2 (b). Results are shown as a
percentage of the total radioactivity released after 48 h, each point
representing the mean of duplicate wells. Data are representatives of
three separate experiments. b: Aliquots of 24 h supernatants from
the same experiment were analysed by gelatin zymography as de-
scribed in Section 2. Lanes 1, 2, uninduced cells; lanes 3, 4, induced
cells; lanes 5, 6, 7, 8, cells incubated with 100, 500, 750, 1000 nM
TIMP 1 respectively; lanes 9, 10, 11, 12, cells incubated with 100,
500, 750 and 1000 nM TIMP 2 respectively.
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dation down to levels comparable to cell free controls. At the
same concentration TIMP 1 was a very poor inhibitor (Fig.
3a). When TIMPs were removed and the cells cultured for a
further 24 h their ability to degrade the collagen was restored.
The results from these experiments suggest that in this cell
system the majority of the collagenolysis observed is likely
to be due to MT1 MMP and that other MMPs have little
involvement. No MMP 13 and only negligible levels (6 2 ng/
ml) of MMP 1 could be detected in association with these cells
by ELISA or Western blotting of concentrated 48 h cell super-
natants (data not shown) and did not vary between induced
and repressed cells.
Gelatin zymography of cell supernatants from these experi-
ments demonstrated that inhibition of MMP 2 activation mir-
rored inhibition of collagen degradation (Fig. 3b). These data
therefore support the previous biochemical data, demonstrat-
ing that TIMP 1 does not act as a regulator of MT1 MMP/
MMP 2 mediated collagenolysis in a cell model. However it
should be noted that TIMP 2 has an apparent inhibition
constant of 6 1 nM when reacted with MT1 MMP in solu-
tion [23], indicating that accessibility of the exogenous TIMP
to degradative sites is poorer in cell model systems.
3.4. 63 kDa MT1 MMP has no collagenolytic activity
Three forms of MT1 MMP can be identi¢ed in lysates from
cells which activate MMP 2. These have molecular masses of
63 kDa, 60 kDa and 45 kDa, corresponding to the pro, fully
active and truncated forms of MT1 MMP [6,24,25]. Some
reports have suggested that the 63 kDa form is not always
cleaved to the 60 kDa form as a prerequisite for catalytic
activity [26], however work published whilst this manuscript
was in preparation demonstrated that processing of MT1
MMP to the 60 kDa form in CHO K1 cells was required
for proteolytic activity. When these cells were co-transfected
with MT1 MMP and K1 antitrypsin Portland (K1PDX), which
was shown to inhibit the processing of proMT1 MMP to the
active 60 kDa form, no degradation of gelatin was observed
compared to cells transfected with MT1 MMP alone [27]. In
order to establish which forms of MT1 MMP were catalyti-
cally active in our cell model we incubated induced HTC 75
cells with or without ionomycin, a calcium ionophore which
has previously been shown to block conversion of MT1 MMP
from the 63 kDa proform to the fully active 60 kDa [28,29].
Collagenolysis was inhibited in a dose responsive manner by
the presence of ionomycin (Fig. 4a). Analysis of cell lysates by
Western blotting revealed that those from cells incubated in
the presence of ionomycin had only a major band of MT1
MMP at 63 kDa compared to lysates from cells induced in the
absence of ionomycin where the predominant MT1 MMP
bands were 60 kDa and 45 kDa (Fig. 4b). These results in-
dicate that ionomycin is able to prevent the generation of fully
mature, active MT1 MMP which is believed to result from
cleavage in the propeptide domain by proprotein convertases
such as furin. The recent study by Yana and Weiss [27] iden-
ti¢ed a proprotein convertase^MT1 MMP axis which allows
both furin dependent and furin independent MT1 MMP pro-
cessing either intracellularly or at the cell surface. At present it
is unclear whether ionomycin, by allowing an intracellular
in£ux of calcium inhibits MT1 MMP processing by prevent-
ing tra⁄cking to the sites of proprotein convertase activity. It
is however clear that 63 kDa MT1 MMP has no proteolytic
activity in this cell model.
3.5. Collagenolysis can be enhanced by the addition of
exogenous proMMP 2
The addition of exogenous proMMP 2 resulted in enhanced
degradation of collagen by the induced cells (Fig. 5). A pro-
portion of this enhanced degradation was due to activation of
MMP 2 by endogenous MT1 MMP since there was also a
signi¢cant dose responsive increase in degradation of collagen
by the non-induced cells (which activate endogenous MMP 2
when cultured on type 1 collagen, Fig. 2). At a dose of 1 Wg/
ml proMMP 2 collagenolysis was enhanced to almost double
that seen in MT1 MMP expressing cells incubated without
added proMMP 2. 500 nM TIMP 2 completely abolished
degradation of collagen by the induced cells cultured in the
presence of 1 Wg/ml of exogenous proMMP 2. However TIMP
1 at the same concentration inhibited the enhanced degrada-
tion only partially (approximately 30%, data not shown)
which suggests either that enhanced collagenolysis was largely
e¡ected by MT1 MMP, or that TIMP 1 was unable to e⁄-
ciently inhibit membrane bound MMP 2. Previous studies
have shown that TIMP 1 may be less e¡ective at inhibiting
MMP 2 in situations where the C-terminal domain is unavail-
able (i.e. membrane bound MMP 2), since an MMP 2 mutant
lacking the C-terminal domain bound TIMP 1 poorly in vitro
[30].
The results from these experiments demonstrate that cell
associated MT1 MMP is an e⁄cient interstitial collagenase.
Expression of MT1 MMP was accompanied by increased ac-
tivation of MMP 2, allowing cooperation between these en-
zymes to facilitate collagenolysis. It is clear that in cell asso-
ciated activation cascades involving membrane tethered
Fig. 4. a: HTC 75 cells were cultured for 48 h on 14C collagen ¢lms
in the absence of doxycycline and varying amounts of ionomycin.
Results are shown as radioactivity released as a percentage of the
total. Each point is mean of three replicate wells. Values for cell
free controls (5^6%) have been subtracted. b: Western blot analysis
of cell lysates from a separate experiment in which cells were cul-
tured on 14C collagen in the absence of doxycycline and in the pres-
ence of 0, 100, 250 or 500 nM ionomycin.
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MMPs relative levels of enzyme and inhibitors are crucial in
determining the overall degradation of ECM components.
Taken together these results provide evidence that MT1
MMP is able to participate in proteolysis of the pericellular
ECM by directly cleaving ¢brillar collagens which are then
susceptible to further degradation. The cell surface associated
nature of this activity provides a focussed and highly regu-
lated mechanism for remodelling the local extracellular envi-
ronment. The phenotype of the MT1 MMP de¢cient mouse
demonstrates that this is particularly important in bone and
cartilage matrix turnover in both development and disease
and the ability to cleave ¢brillar collagens is of crucial impor-
tance in these processes. It is interesting to speculate what the
role of the ‘traditional’ speci¢c interstitial collagenases MMP
1 and MMP 13 might be relative to MT1 MMP. The impor-
tance of MMP 1 for cell migration on collagen has been
demonstrated for keratinocytes and other epithelial cells
[31]. We can further speculate that proteolytic cascades which
can be regulated very speci¢cally may be involved in other
processes which require focussed degradation of the ECM.
In this laboratory co-workers have shown that tubule forma-
tion by human umbilical vein endothelial cells grown in ¢brin
gels involves MT MMP expression and can be inhibited by
TIMP 2 but not by TIMP 1. A point mutated form of TIMP
2, which is known to have a greatly increased Ki value for
MT1 MMP and is therefore a poor inhibitor of MT1 MMP
compared to MMP 2 where inhibition is largely una¡ected
[23], was however unable to inhibit tubule formation (M. La-
£eur and D. Edwards, personal communication). These data
invoke a role for cell associated MT1 MMP in angiogenesis.
Similar mechanisms are most likely involved in well docu-
mented studies correlating MT1 MMP and MMP 2 expres-
sion and activation in tumour cell migration.
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the presence (light shading) or absence (dark shading) of 100 ng/ml
doxycycline. Exogenous proMMP 2 was added at the concentrations
indicated to three replicate wells. Results are shown as radioactivity
released as a percentage of the total with values for cell free con-
trols subtracted.
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